RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Carl Zeiss Meditec Stock

Carl Zeiss Meditec Revenue 2024

Carl Zeiss Meditec Revenue

2.1 B EUR

Ticker

AFX.DE

ISIN

DE0005313704

WKN

531370

In 2024, Carl Zeiss Meditec's sales reached 2.1 B EUR, a 0.46% difference from the 2.09 B EUR sales recorded in the previous year.

The Carl Zeiss Meditec Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2028e2.9441,00
2027e2.8741,97
2026e2.5148,00
2025e2.3351,84
2024e2.157,44
20232.0957,71
20221.959,26
20211.6558,73
20201.3455,83
20191.4657,00
20181.2855,46
20171.1955,19
20161.0953,25
20151.0451,89
20140.9153,71
20130.9153,82
20120.8653,53
20110.7654,67
20100.6853,01
20090.6450,35
20080.650,55
20070.5751,87
20060.3947,06
20050.3247,08
20040.2346,40

Carl Zeiss Meditec Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Carl Zeiss Meditec, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Carl Zeiss Meditec from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Carl Zeiss Meditec’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Carl Zeiss Meditec. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Carl Zeiss Meditec’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Carl Zeiss Meditec’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Carl Zeiss Meditec’s growth potential.

Carl Zeiss Meditec Revenue, EBIT and net profit per share

DateCarl Zeiss Meditec RevenueCarl Zeiss Meditec EBITCarl Zeiss Meditec Net Income
2028e2.94 B undefined587.87 M undefined410.76 M undefined
2027e2.87 B undefined549.49 M undefined391.99 M undefined
2026e2.51 B undefined442.16 M undefined297.29 M undefined
2025e2.33 B undefined361.23 M undefined241.91 M undefined
2024e2.1 B undefined255.08 M undefined174.77 M undefined
20232.09 B undefined348.12 M undefined290.4 M undefined
20221.9 B undefined396.88 M undefined293.91 M undefined
20211.65 B undefined371.17 M undefined236.28 M undefined
20201.34 B undefined177.55 M undefined122.39 M undefined
20191.46 B undefined264.66 M undefined159.76 M undefined
20181.28 B undefined197.13 M undefined126.46 M undefined
20171.19 B undefined173.35 M undefined134.45 M undefined
20161.09 B undefined154.33 M undefined98.33 M undefined
20151.04 B undefined130.59 M undefined62.3 M undefined
2014909.3 M undefined120.7 M undefined75 M undefined
2013906.4 M undefined133.9 M undefined93.5 M undefined
2012861.9 M undefined122.9 M undefined71.9 M undefined
2011758.8 M undefined103.6 M undefined66.9 M undefined
2010676.7 M undefined86.5 M undefined54.9 M undefined
2009640.1 M undefined76.2 M undefined50.5 M undefined
2008600.2 M undefined68.2 M undefined54 M undefined
2007569.7 M undefined70.4 M undefined47.8 M undefined
2006390.6 M undefined47.8 M undefined26.7 M undefined
2005323.7 M undefined36.3 M undefined17.1 M undefined
2004234.9 M undefined25.5 M undefined12.6 M undefined

Carl Zeiss Meditec stock margins

The Carl Zeiss Meditec margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Carl Zeiss Meditec. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Carl Zeiss Meditec.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Carl Zeiss Meditec's sales revenue. A higher gross margin percentage indicates that the Carl Zeiss Meditec retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Carl Zeiss Meditec's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Carl Zeiss Meditec's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Carl Zeiss Meditec's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Carl Zeiss Meditec. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Carl Zeiss Meditec's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Carl Zeiss Meditec Margin History

Carl Zeiss Meditec Gross marginCarl Zeiss Meditec Profit marginCarl Zeiss Meditec EBIT marginCarl Zeiss Meditec Profit margin
2028e57.71 %19.99 %13.97 %
2027e57.71 %19.13 %13.64 %
2026e57.71 %17.6 %11.83 %
2025e57.71 %15.53 %10.4 %
2024e57.71 %12.15 %8.33 %
202357.71 %16.66 %13.9 %
202259.26 %20.86 %15.45 %
202158.73 %22.54 %14.35 %
202055.83 %13.3 %9.16 %
201957 %18.14 %10.95 %
201855.46 %15.39 %9.87 %
201755.19 %14.57 %11.3 %
201653.25 %14.18 %9.03 %
201551.89 %12.56 %5.99 %
201453.71 %13.27 %8.25 %
201353.82 %14.77 %10.32 %
201253.53 %14.26 %8.34 %
201154.67 %13.65 %8.82 %
201053.01 %12.78 %8.11 %
200950.35 %11.9 %7.89 %
200850.55 %11.36 %9 %
200751.87 %12.36 %8.39 %
200647.06 %12.24 %6.84 %
200547.08 %11.21 %5.28 %
200446.4 %10.86 %5.36 %

Carl Zeiss Meditec Aktienanalyse

What does Carl Zeiss Meditec do?

Carl Zeiss Meditec AG is a globally leading provider of medical technologies and devices for diagnostics and therapy. The company's history dates back to the founding of Carl Zeiss in 1846 in Jena, Germany. It has a long tradition in the development and manufacture of optical devices, particularly microscopes and binoculars. In 1996, Carl Zeiss decided to spin off its medical technology business segment and establish Carl Zeiss Meditec AG. Since then, the company has developed a wide portfolio of products used in ophthalmology and other medical fields. The business model of Carl Zeiss Meditec is based on three pillars: devices for diagnostics and therapy, software, and services. The devices are offered in various divisions specialized in specific application areas. The ophthalmology division is the largest and most well-known area of the company. It offers a wide range of diagnostic and therapy devices used in the treatment of eye diseases such as glaucoma, cataract, and retinal disorders. The products of the ophthalmology division include OCT systems (optical coherence tomography) for detailed examination of the retina, as well as VisuMax laser technology for correction of vision defects. Another important area of Carl Zeiss Meditec is the neurosurgery division. It offers devices for stereotactic neurosurgery used in the treatment of brain tumors, movement disorders, and other neurological conditions. The products of this division include the Kinevo stereotactic navigation system and the OPMI Neuro/NC4 surgical microscope series. In the dental division, Carl Zeiss Meditec provides innovative solutions for dentistry. This includes optical impression systems (Artemis), CAD/CAM systems, and dental microscopes. In addition to products, Carl Zeiss Meditec also offers software solutions for medical imaging and data processing. The FORUM software platform allows for intuitive management of medical images and findings. The company also provides training and education for doctors and medical professionals. The products of Carl Zeiss Meditec are known for their high quality, reliability, and precision. The company focuses on innovative technologies and continuously invests in research and development to strengthen its position as a market leader in the medical technology industry. Carl Zeiss Meditec is present in more than 60 countries worldwide and employs around 3,000 people. It is headquartered in Jena, Germany, and has additional locations in the United States, Canada, China, India, and other countries. Overall, Carl Zeiss Meditec AG is an innovative and reliable partner for the medical technology industry. Its wide range of products and services contributes to improving the health of millions of people worldwide. Carl Zeiss Meditec ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Carl Zeiss Meditec's Sales Figures

The sales figures of Carl Zeiss Meditec originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Carl Zeiss Meditec’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Carl Zeiss Meditec's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Carl Zeiss Meditec’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Carl Zeiss Meditec stock

How much revenue did Carl Zeiss Meditec generate this year?

Carl Zeiss Meditec has achieved a revenue of 2.1 B EUR this year.

How much was the turnover of the company Carl Zeiss Meditec compared to the previous year?

The revenue of Carl Zeiss Meditec has increased by 0.46% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Carl Zeiss Meditec?

The revenue of Carl Zeiss Meditec is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Carl Zeiss Meditec measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Carl Zeiss Meditec so important for investors?

The revenue of Carl Zeiss Meditec is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Carl Zeiss Meditec pay?

Over the past 12 months, Carl Zeiss Meditec paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 1.89 %. For the coming 12 months, Carl Zeiss Meditec is expected to pay a dividend of 1.22 EUR.

What is the dividend yield of Carl Zeiss Meditec?

The current dividend yield of Carl Zeiss Meditec is 1.89 %.

When does Carl Zeiss Meditec pay dividends?

Carl Zeiss Meditec pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Carl Zeiss Meditec?

Carl Zeiss Meditec paid dividends every year for the past 20 years.

What is the dividend of Carl Zeiss Meditec?

For the upcoming 12 months, dividends amounting to 1.22 EUR are expected. This corresponds to a dividend yield of 2.09 %.

In which sector is Carl Zeiss Meditec located?

Carl Zeiss Meditec is assigned to the 'Health' sector.

Wann musste ich die Aktien von Carl Zeiss Meditec kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Carl Zeiss Meditec from 3/26/2024 amounting to 1.1 EUR, you needed to have the stock in your portfolio before the ex-date on 3/22/2024.

When did Carl Zeiss Meditec pay the last dividend?

The last dividend was paid out on 3/26/2024.

What was the dividend of Carl Zeiss Meditec in the year 2023?

In the year 2023, Carl Zeiss Meditec distributed 0.9 EUR as dividends.

In which currency does Carl Zeiss Meditec pay out the dividend?

The dividends of Carl Zeiss Meditec are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Carl Zeiss Meditec stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von Carl Zeiss Meditec

Our stock analysis for Carl Zeiss Meditec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carl Zeiss Meditec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.